Skip to main content
SpringerLink
Log in

Eales’ Disease

  • Chapter
  • First Online:
Retinal Vascular Disease

Part of the book series: Retina Atlas ((RA))

  • 565 Accesses

Abstract

Eales’ disease is an idiopathic retinal periphlebitis that primarily affects the peripheral retina in young adults. The disease is more commonly seen in the Indian subcontinent. Eales’ disease is characterized by retinal periphlebitis, peripheral retinal ischemia and neovascularization. Visual loss is characteristically caused by recurrent vitreous hemorrhage. Corticosteroids remain the main stage of treatment during the inflammatory stage. Laser photocoagulation and anti-VEGF therapy is effective in the proliferative stage. Vitreoretinal surgery is helpful in management of non-resolving vitreous hemorrhage and complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales disease. Ocul Immunol Inflammol. 1993;1:41–8.

    Article  CAS  Google Scholar 

  • Bali T, Saxena S, Kumar D, et al. Response time and efficacy of oral methotrexate pulsed therapy in idiopathic retinal periphlebitis. Eur J Ophthalmol. 2005;15:374–8.

    Article  CAS  Google Scholar 

  • Bhooma V, Sulochana KN, Biswas J, et al. Eales’ disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res. 1997;16:91–5.

    Article  CAS  Google Scholar 

  • Biswas J, Therese L, Madhavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous samples of Eales’ disease. Br J Ophthalmol. 1999;83:994.

    Article  CAS  Google Scholar 

  • Cross AG. Vasculitis retinae. Trans Ophthalmol Soc. 1963;83:133.

    CAS  Google Scholar 

  • Das T, Biswas J, Kumar A, et al. Eales’disease. Ind J Ophthalmol. 1994;42:3–18.

    CAS  Google Scholar 

  • Duke-Elder S, Dobree JH. Primary perivasculitis of the retina: eales disease. In: Elder D, Perkins EJ, editors. System of ophthalmology, vol. X. London: Henry Kimpton; 1967.

    Google Scholar 

  • Eales H. Retinal haemorrhage associated with epistaxis and constipation. Brim Med Rev. 1880;9:262.

    Google Scholar 

  • Eales H. Primary retinal haemorrhage in young men. Ophthalmic Rev. 1882;1:41.

    Google Scholar 

  • El-Asrar AM, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales’ disease). Br J Ophthalmol. 2002;86:1248–51.

    Article  Google Scholar 

  • Elliot AJ. 30-year observation of patients with Eales disease. Am J Ophthalmol. 1975;80:404–8.

    Article  CAS  Google Scholar 

  • Gilbert TW. Periphlebitis and endovasculitis of retinal vessels. Klin Monatsbl Augenheilkd. 1935;94:335–49.

    Google Scholar 

  • Keith-Lyle T, Wybark A. Retinal vasculitis. Br J Ophthalmol. 1961;45:77–8.

    Google Scholar 

  • Kimura SJ, Carriker FR, Hogen MJ. Retinal vasculitis with intraocular hemorrhage: classification and results of special studies. Arch Ophthalmol. 1956;56:361–5.

    Article  Google Scholar 

  • Kumar D, Saxena RC, Saxena S. Vitreous hemorrhage in Eales’ disease. Afro-Asian J Ophthalmol. 1995;13:109–12.

    Google Scholar 

  • Kumar A, Tiwari HK, Singh RP. Comparative evaluation of early vs deferred vitrectomy in Eales’ disease. Acta Ophthalmol Scand. 2000;78:77–8.

    Article  CAS  Google Scholar 

  • Madhavan HN, Therese KL, Doraiswamy K. Further investigations on the association of Mycobacterium tuberculosis with Eales’ disease. Ind J Ophthalmol. 2002;50:35–9.

    Google Scholar 

  • Madhavan HN, Therese KL, Gunisha P. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease. Invest Ophthalmol Vis Sci. 2000;41:822–5.

    CAS  PubMed  Google Scholar 

  • Perentes Y, Chan CC, Bovey E. Massive vascular endothelium growth factor (VEGF) expression in Eales’ disease. Klin Monatsbl Augenheilkd. 2002;219:311–4.

    Article  Google Scholar 

  • Saxena S, Khanna VK, Kumar D. Impaired antioxidant defense mechanism in central Eales’ disease. Ann Ophthalmol. 2004;36:29–31.

    Article  Google Scholar 

  • Saxena S, Khanna VK, Kumar D, et al. Enhanced oxidative stress in Eales’ disease. Ann Ophthalmol. 2001;33:40–2.

    Article  Google Scholar 

  • Saxena S, Khanna VK, Pant AB, et al. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative Eales’ disease. Pathobiology. 2011;78:261–65.

    Google Scholar 

  • Saxena S, Kumar D. Visual outcome in Eales’ disease with branch retinal vein occlusion. Ann Ophthalmol. 1999;31:173–5.

    Google Scholar 

  • Saxena S, Kumar D. Macular involvement in Eales’ disease. Ann Ophthalmol. 2000;32:98–100.

    Article  Google Scholar 

  • Saxena S, Kumar D. Visual outcome in central Eales’ disease. Ann Ophthalmol. 2001;33:300–2.

    Article  Google Scholar 

  • Saxena S, Kumar D. A new staging system of idiopathic retinal periphlebitis. Eur J Ophthalmol. 2004;14:236–9.

    Article  CAS  Google Scholar 

  • Saxena S, Kumar D. Topographic distribution of retinal neovascularisation in Eales’ disease. Ann Ophthalmol. 2005;37:273–5.

    Article  Google Scholar 

  • Saxena S, Kumar D, Kapoor S. The efficacy of oral methotrexate pulsed therapy in Eales’ disease. Ann Ophthalmol. 2000;32:60–2.

    Article  Google Scholar 

  • Saxena S, Kumar D, Maitreya A. Retinal neovascularization in Eales disease. Ann Ophthalmol. 2003;35:25–7.

    Article  Google Scholar 

  • Saxena S, Kumar D, Srivastava P, et al. Low levels of platelet glutathione in Eales’ disease. Med Sci Res. 1999;42:125–6.

    Google Scholar 

  • Saxena S, Pant AB, Khanna, et al. Interleukin-1 and tumor necrosis factor-alpha: Novel Targets for Immunotherapy in Eales Disease. Ocul Immunol Inflamm. 2009;17:201–06.

    Google Scholar 

  • Saxena S, Pant AB, Khanna VK, et al. Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales’ disease): implication for anti-TNF-α therapy. J Ocul Bio Dis Infor. 2010;3:35–38.

    Google Scholar 

  • Saxena S, Rajasingh J, Biswas S, et al. Cellular response to retinal S-antigen and Interphotoreceptor retinoid binding protein fragments in patients with Eales' disease. Pathobiology. 1999;67:37–44.

    Article  Google Scholar 

  • Saxena S, Srivastava P, Khanna VK. Antioxidant supplementation improves platelet membrane fluidity in idiopathic retinal periphlebitis (Eales’ Disease). J Ocul Pharm Ther. 2010;26:623–26.

    Google Scholar 

  • Saxena S, Srivastava P, Kumar D. Decreased platelet membrane fluidity in retinal periphlebitis in Eales’ disease. Ocul Immunol Inflamm. 2006;14:113–6.

    Article  CAS  Google Scholar 

  • Shanmugam MP, Badrinath SS, Gopal L. Long term visual results of vitrectomy for Eales disease complications. Int Ophthalmol. 1998;22:61–4.

    Article  CAS  Google Scholar 

  • Srivastava P, Saxena S, Khanna VK, et al. Raised platelet thiobarbituric acid reacting substances in proliferative Eales disease. Indian J Ophthalmol. 2000;48:307–10.

    CAS  PubMed  Google Scholar 

  • Sulochana KN, Biswas J, Ramakrishnan S. Eales’ disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and antioxidant enzymes and reduced glutathione in vitreous. Curr Eye Res. 1999;19:254–9.

    Article  CAS  Google Scholar 

  • Swamy-Mruthinti S, Miriam KC, Kumar SK. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization. Curr Eye Res. 2002;25:139–45.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, King George’s Medical University, Lucknow, India

    Sandeep Saxena

Authors
  1. Sandeep Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA

    Alan Sheyman

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Amani A. Fawzi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saxena, S. (2020). Eales’ Disease. In: Sheyman, A., Fawzi, A.A. (eds) Retinal Vascular Disease. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-15-4075-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4075-2_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4074-5

  • Online ISBN: 978-981-15-4075-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation